Sequoia Capital

Sequoia Capital is a global venture capital firm, founded in 1972, specializing in early-stage and growth investments across technology, healthcare, and consumer sectors. With offices worldwide, Sequoia manages multiple funds and has invested in over 350 companies that have become public or achieved significant valuations.

Rohit Agarwal

Managing Director

Mohit Bhatnagar

Managing Director

Wang Chenyu

Vice President

Sakshi Chopra

Managing Director

Shmil Levy

Investor

Ishaan Mittal

Managing Director

Abhishek Mohan

Principal

Javier Ng

Associate

Enita Pu

Partner

Yoav Shaked

Investor

Pavel Vyhnalek

Operating Partner

Fu Xin

Partner

Past deals in Eastern Asia

Naen Auto

Venture Round in 2024
Shanghai NAEN Auto Technology Co., Ltd. specializes in the development and manufacturing of automotive electronics tailored for automobile manufacturers. The company offers a range of advanced products including passive entry passive start systems, electronic steering column locks, smart air conditioning systems, body control modules, heads-up display systems, domain control units, capacitive sensors, and kick sensors. By providing these innovative solutions, NAEN Auto enables automotive manufacturers to enhance the intelligence and functionality of their vehicles.

RD Technologies

Series A in 2024
RD Technologies Group (RD Technologies) is a financial platform that bridges the Web2 and Web3 worlds. RD Technologies' secure and innovative solutions include: • RD Wallet: RD Wallet Technologies Limited (RD Wallet) is a licensed Stored Value Facility in Hong Kong (licence number: SVF0016). It enables global businesses to open multi-currency fiat accounts on mobile anytime, anywhere. • HKDR Stablecoin (HKDR): HKDR Stablecoin (HKDR) is a compliant and transparent Hong Kong Dollar stablecoin 1:1 backed by the Hong Kong dollar, with high-quality and highly liquid assets safekept in segregated custody accounts with licensed financial institutions. Details of the reserves will be available to the public through regular independent attestation reports. In July 2024, RD InnoTech Limited, the issuer of HKDR, was among the first batch of entities to be admitted to the stablecoin issuer sandbox by the Hong Kong Monetary Authority. • HKDR Stablecoin (HKDR): HKDR Stablecoin (HKDR) is a compliant and transparent Hong Kong Dollar stablecoin 1:1 backed by the Hong Kong dollar, with high-quality and highly liquid assets safekept in segregated custody accounts with licensed financial institutions. Details of the reserves will be available to the public through regular independent attestation reports. In July 2024, RD InnoTech Limited, the issuer of HKDR, was among the first batch of entities to be admitted to the stablecoin issuer sandbox by the Hong Kong Monetary Authority.

Xiaohongshu

Secondary Market in 2024
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.

Xiaohongshu

Secondary Market in 2023
Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.

Neurophth Therapeutics

Series C in 2023
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Micro Connect

Series C in 2023
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.

SUNRATE

Series D in 2023
SUNRATE is a global payment and treasury management platform established in 2016, headquartered in Singapore with additional offices in Hong Kong, Jakarta, London, and Shanghai. The company provides a comprehensive solution for businesses to operate and scale internationally across over 190 countries and regions. SUNRATE's platform offers services such as international payments, virtual corporate cards, global collections, and treasury management, facilitating smooth commercial transactions and enhancing international trade. By leveraging its proprietary technology and extensive global network, SUNRATE partners with leading financial institutions like Citibank and Standard Chartered, and holds principal memberships with both Mastercard and Visa, positioning itself as a key player in the financial technology sector.

Shein

Venture Round in 2023
Founded in 2008, Shein is a global online marketplace specializing in women's fast fashion. It uses on-demand manufacturing technologies to connect suppliers with an agile supply chain, reducing inventory waste and offering affordable clothing, shoes, jewelry, and accessories to customers worldwide.

DeepLang AI

Venture Round in 2023
DeepLang AI is focused on developing a sophisticated information processing engine tailored for the Chinese market. Utilizing advanced artificial intelligence and natural language processing technologies, the company offers a range of capabilities including AI-generated content text generation, information extraction, aggregation, and semantic retrieval. This intelligent engine is designed to support workers and organizations in China, enhancing their productivity and efficiency in managing and analyzing textual data within information-intensive environments. By leveraging its self-developed large-scale model, DeepLang AI aims to provide robust solutions that address the unique challenges faced in processing and understanding large volumes of information.

Phabuilder

Series A in 2023
PhaBuilder is a technology-driven company established in February 2021 by Professor Guoqiang Chen, specializing in synthetic biology with a focus on the engineering application of halophilic microbes. The company employs advanced techniques in Next Generation Industrial Biotechnology to create high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine, and cadaverine, targeting multiple sectors, including materials and pharmaceuticals. PhaBuilder is currently constructing two PHA production facilities in China and aims to establish 3-5 large-scale production sites within five years. The company utilizes an interdisciplinary approach that combines biology, engineering, and information technology to transform genetic programs, thereby offering sustainable solutions across diverse fields. With significant backing from notable investors, PhaBuilder is dedicated to integrating synthetic biotechnology into everyday life and advancing intelligent biological manufacturing, with the overarching goal of fostering a greener future through microbial innovation.

Locad

Series A in 2023
Locad enables e-commerce brands to expand omnichannel operations across Asia-Pacific by providing a logistics engine that automates storage, packing, shipping, and tracking of orders. Its cloud-based platform synchronizes inventory across online channels and facilitates end-to-end order fulfillment through a network of warehouses and carriers in Singapore, the Philippines, Thailand, Hong Kong, and Australia.

Haawking

Series A in 2022
Haawking specializes in developing and manufacturing industrial control microprocessors and machine vision chips. Their products enhance computing efficiency and reduce costs for clients across industries such as industrial robots, augmented reality, autonomous driving, consumer electronics, and new energy automotive.

Zhonghai Chuneng Technology Beijing

Seed Round in 2022
Zhonghai Chuneng Technology Beijing develops energy storage technology and the production, and sales of energy storage equipment.

Cataya Bio

Series A in 2022
Cataya Bio (Shanghai) Co., Ltd. is a biotechnology company focused on developing synthetic biological products for various industries. Utilizing an advanced engineering biology platform, Cataya Bio engineers microbes and implements clean fermentation processes to produce high-purity products efficiently and sustainably. The company aims to facilitate the transition from petroleum-based materials to natural and sustainable raw materials, addressing critical global challenges such as environmental preservation, carbon emissions, and climate change. Through its innovative approach, Cataya Bio provides clients with effective solutions for sourcing raw materials that align with contemporary sustainability goals.

Insight Lifetech

Series D in 2022
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

XellSmart

Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

LegalForce

Series D in 2022
LegalForce, Inc. is a Tokyo-based company founded in 2017 that specializes in developing software for legal services. It operates an AI-powered contract management platform designed to assist legal professionals in contract review. By utilizing natural language processing and other advanced technologies, LegalForce's platform helps users analyze contracts based on their specific types, while identifying potentially omitted or risky clauses. This functionality aids legal professionals in preventing oversights and enhancing the quality and efficiency of their operations, ultimately strengthening their legal systems.

LegalOn Technologies

Series D in 2022
LegalOn is an AI-driven platform specializing in contract review. It leverages AI, legal content, and team knowledge to identify potential risks, suggest redlines, and structure contract data, thereby enhancing efficiency in legal processes.

Mech-Mind Robotics

Series C in 2022
Mech-Mind Robotics Technologies is a prominent manufacturer based in Beijing, China, specializing in hardware and software solutions for the logistics industry. Founded in 2016, the company produces advanced smart cameras, including the Mech-Eye series, which are designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind also develops AI-powered software that enables robotic cameras to identify and process objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in tackling complex automation challenges, including bin picking and assembly tasks, thereby enhancing operational efficiency in the e-commerce and logistics sectors. The company further extends its reach with an office in Munich, Germany, and a sales office in Shanghai, China.

HAI ROBOTICS

Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.

NuProbe

Series B in 2022
NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Supreium Technology

Series A in 2022
Supreium Technology is a developer of advanced die-casting computer-aided engineering (CAE) simulation software, specializing in intelligent manufacturing solutions. Founded in 2016 and based in Beijing, China, the company offers a software as a service (SaaS) platform that includes a range of services such as mold design, injection process analysis, and automatic defect detection through image scanning. Supreium also provides process consulting, focusing on areas like gate and runner design as well as thermal balance analysis. Its solutions cater to various industries, including medical treatment, marine water conservancy, communications, and industrial sectors. The company emphasizes intelligent algorithms and high-performance CAE technologies to deliver innovative digital solutions for its clients.

EPiCMEMS

Series A in 2022
Kaiyuan Communication Technology (Xiamen) Co., Ltd. is a specialized chip manufacturer based in Haicang District, Xiamen City. The company focuses on providing RF front-end solutions, developing advanced 4G+ and 5G RF filters and chips aimed at enhancing the domestic chip industry. With operational facilities in Zhangjiang, Shanghai, and sales and customer support centers in Shenzhen, Xi'an, and Beijing, Kaiyuan is positioned to serve the mobile device sector and the burgeoning Internet of Things (IoT) market. Its products are designed to deliver high-speed, high-quality connectivity, enabling users to experience faster and more stable connections in their devices.

KAWO 科握

Series A in 2022
KAWO Technology LLC, founded in 2013 and based in Shanghai, specializes in providing social media solutions for international brands seeking to engage with Chinese audiences. The company develops an application that facilitates the creation and sharing of short-form videos and GIFs, specifically tailored for platforms such as Weibo and WeChat. KAWO's innovative tools enable brands to maintain authenticity and consistency across their social media channels while integrating Western platforms like Facebook and Twitter with their Chinese counterparts. By offering data insights and promoting transparency, KAWO enhances operational efficiency for global teams, allowing them to navigate the rapidly evolving Chinese social media landscape effectively.

Shein

Series F in 2022
Founded in 2008, Shein is a global online marketplace specializing in women's fast fashion. It uses on-demand manufacturing technologies to connect suppliers with an agile supply chain, reducing inventory waste and offering affordable clothing, shoes, jewelry, and accessories to customers worldwide.

Micro Connect

Series B in 2022
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.

XVERSE

Series A in 2022
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.

Inceptio Technology

Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Insider

Series D in 2022
Insider is a growth management platform that assists digital marketers in optimizing their strategies across the entire marketing funnel, from acquisition to retention and revenue generation. Founded in 2012 and headquartered in Singapore, the company utilizes advanced artificial intelligence and machine learning technologies to provide real-time predictive segmentation. This enables marketers to create personalized customer journeys across various channels, including web, mobile, and advertising platforms. Insider's unified data layer simplifies implementation and usage, reducing reliance on complex IT integrations. The platform is designed to minimize marketing waste by enhancing cross-channel customer experiences and optimizing return on ad spend. With a focus on delivering insights that enhance personalization efforts, Insider serves a diverse range of industries, including retail, finance, automotive, and travel, and has established a global presence with offices in multiple countries.

WeShine Network

Series B in 2022
WeShine Network is a marketing and service platform based in Nanjing, China, established in 2015. The company specializes in providing integrated marketing solutions, primarily utilizing the WeChat platform to facilitate corporate account management for business users. WeShine Network enables enterprises to attract and acquire customers through various channels, enhancing their marketing precision and broadening their customer base. With over 150,000 businesses served and more than 30,000 paid enterprise users, the company has built a substantial presence globally, supported by a network of over 600 channel partners. Its offices are located in major cities such as Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.

Amber Group

Series B in 2022
Founded in Hong Kong in 2017 by finance professionals from Morgan Stanley and Goldman Sachs, Amber Group is a global crypto finance service provider. It offers liquidity provision, trading, and asset management services to over 200 institutional clients worldwide, facilitating trades worth $100-200 million daily across multiple exchanges.

SceneRay

Series D in 2022
SceneRay Co. Ltd, based in Singapore Industrial Park in Suzhou, China, is a medical device company specializing in the design, development, and distribution of neuromodulation devices. The company focuses on creating advanced medical products, including a dual-channel implantable pulse generator kit for deep brain stimulation. This technology is designed to provide effective treatments for patients suffering from brain damage through electric stimulation. SceneRay's core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. The company holds numerous patents and is committed to exploring innovative solutions in the field of neuromodulation, aiming to deliver high-quality and effective treatments to improve patient outcomes.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia, designed to connect small businesses seeking loans with lenders looking to fund these loans. By leveraging technology, Modalku offers borrowers access to financing options that may not be available through traditional channels, often at lower interest rates. Lenders participating in the platform can achieve returns that surpass those typically found in bank deposits and traditional investment products. This marketplace lending model has been successfully implemented in various countries, including the USA, UK, China, and Singapore, demonstrating its effectiveness in supporting small business growth.

Qianglian Zhichuang

Series C in 2022
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Tongxin Medical Equipment

Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency

Phabuilder

Venture Round in 2022
PhaBuilder is a technology-driven company established in February 2021 by Professor Guoqiang Chen, specializing in synthetic biology with a focus on the engineering application of halophilic microbes. The company employs advanced techniques in Next Generation Industrial Biotechnology to create high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine, and cadaverine, targeting multiple sectors, including materials and pharmaceuticals. PhaBuilder is currently constructing two PHA production facilities in China and aims to establish 3-5 large-scale production sites within five years. The company utilizes an interdisciplinary approach that combines biology, engineering, and information technology to transform genetic programs, thereby offering sustainable solutions across diverse fields. With significant backing from notable investors, PhaBuilder is dedicated to integrating synthetic biotechnology into everyday life and advancing intelligent biological manufacturing, with the overarching goal of fostering a greener future through microbial innovation.

Vibrant

Venture Round in 2022
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.

Virtue Diagnostics

Series B in 2022
Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic (IVD) company based in Suzhou, China, with a research and development office in Singapore. Founded in 2019, the company specializes in developing advanced diagnostic platforms for the detection of infectious diseases, cancer, and chronic diseases. Its technology offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Virtue Diagnostics aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

Parametrix.ai

Series B in 2022
Parametrix.ai is a startup focused on revolutionizing game development through advanced artificial intelligence solutions. Founded in 2019 and headquartered in China, the company specializes in integrating AI capabilities into gaming scenarios, utilizing technologies such as machine learning and reinforcement learning. Parametrix.ai aims to create AI-driven virtual beings that coexist within a richly developed virtual world, enhancing the gaming experience by enabling complex environmental interactions, decision-making, and dynamic modeling of challenges such as team formation and player survival. By fostering collaboration between humans and AI, Parametrix.ai seeks to build an engaging, innovative, and inclusive gaming environment.

Treelab

Series A in 2021
Treelab is a technology company founded in 2019 and based in Shanghai, China, that specializes in developing a productivity tool designed for non-technical users to create customized business systems without the need for programming skills. Its platform enables organizations to design and manage various business processes, including project management, customer relationship management, and human resource management. Treelab's software facilitates the creation of personalized solutions by allowing users to visualize records, compile data, and compare pricing, all while collaborating in real-time. By streamlining the sourcing process and connecting brands with accredited global factories, Treelab provides a user-friendly digital environment for managing products, suppliers, orders, and invoices efficiently.

Recurrent.ai

Venture Round in 2021
Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company utilizes advanced machine learning technologies to analyze sales calls and conversations, transforming voice interactions into text for comprehensive analysis. Its offerings include a self-study engine for sales dialogue, which allows businesses to generate detailed big data dialogue analysis reports and maintain customer portrait records. By automating these processes, Recurrent.ai helps organizations reduce time and labor costs, improve sales conversion rates, and enhance overall decision-making capabilities.

Tungee

Series B in 2021
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.

QianDao App

Series B in 2021
QianDao App is a company based in Putuo District, Shanghai, China, specializing in the development of blind box toy and garage kit trading software targeted at youth. Founded in 2019, the platform allows users to customize and order toys based on their individual preferences. Among its primary offerings are the Happy Train and Wedding Flower Girl series, which cater to a vibrant community of garage kit enthusiasts and collectors in China. By combining technology with creative expression, QianDao App fosters engagement and interaction within this niche market.

Beijing Sudo Technology

Series A in 2021
Beijing Sudo Technology specializes in privacy protection services through comprehensive engineering solutions. The company has developed an encryption platform that enables secure data collaboration by utilizing advanced technologies such as cryptography, federated learning, and robust data engineering. This platform facilitates multi-party data collaboration while ensuring that original data remains untransmitted, allowing clients to work together securely and privately.

Neurophth Therapeutics

Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

ThinkingData

Series C in 2021
ThinkingData operates a big data analysis platform specifically designed for the gaming industry. The company utilizes advanced natural language processing and text mining technologies to provide users with real-time insights into player behavior, feedback, and public opinion on products. This comprehensive analysis aids gaming businesses in optimizing product experiences, enhancing operational efficiency, and driving user engagement and revenue growth. By offering a self-service data acquisition system, ThinkingData improves data awareness and analysis capabilities for its clients, enabling them to achieve greater data efficiency while reducing analytical costs.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. is a Shenzhen, China-based company that specializes in the design and development of advanced surgical equipment. Founded on May 4, 2017, the company is dedicated to researching and promoting cutting-edge smart technologies aimed at enhancing surgical safety and treatment efficacy. By focusing on the pursuit of excellence and refinement in its products, Edge Medical Robotics seeks to elevate health standards and improve overall social health outcomes.

KAWO 科握

Seed Round in 2021
KAWO Technology LLC, founded in 2013 and based in Shanghai, specializes in providing social media solutions for international brands seeking to engage with Chinese audiences. The company develops an application that facilitates the creation and sharing of short-form videos and GIFs, specifically tailored for platforms such as Weibo and WeChat. KAWO's innovative tools enable brands to maintain authenticity and consistency across their social media channels while integrating Western platforms like Facebook and Twitter with their Chinese counterparts. By offering data insights and promoting transparency, KAWO enhances operational efficiency for global teams, allowing them to navigate the rapidly evolving Chinese social media landscape effectively.

Cellular Biomedicine Group

Series A in 2021
Cellular Biomedicine Group, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer and stem cell therapies for degenerative diseases in Greater China. The company employs proprietary cell-based technologies, including various forms of CAR-T therapy, which targets different cancer types, and human adipose-derived mesenchymal progenitor cells aimed at treating joint diseases. Its product pipeline features therapies such as CD20 and CD22 CAR-T for B cell malignancies, and alpha fetoprotein TCR-T targeting hepatocellular carcinoma. Additionally, Cellular Biomedicine is developing knee osteoarthritis treatments, including AlloJoin and Re-Join, the latter having completed Phase IIb trials. The company also engages in broader biopharmaceutical activities, encompassing research and development, technical support, and manufacturing of pharmaceutical polypeptides and medical devices. It has established a partnership with Novartis Pharma AG to produce and supply the CAR-T cell therapy Kymriah in China. Founded in 2001, Cellular Biomedicine Group is headquartered in New York, New York, and draws on a wealth of cellular medicine research and expertise from scientists and clinicians across the United States, England, and China.

Mech-Mind Robotics

Series C in 2021
Mech-Mind Robotics Technologies is a prominent manufacturer based in Beijing, China, specializing in hardware and software solutions for the logistics industry. Founded in 2016, the company produces advanced smart cameras, including the Mech-Eye series, which are designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind also develops AI-powered software that enables robotic cameras to identify and process objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in tackling complex automation challenges, including bin picking and assembly tasks, thereby enhancing operational efficiency in the e-commerce and logistics sectors. The company further extends its reach with an office in Munich, Germany, and a sales office in Shanghai, China.

Xreal

Series C in 2021
Founded in 2017, Xreal is a pioneering developer of ready-to-wear mixed reality glasses. Its flagship product, Nreal Light, offers lightweight comfort and vivid display, enhanced by spatial computing algorithms for an immersive user experience. The company's mission is to make mixed reality accessible to all, empowering developers to create innovative applications across entertainment and productivity.

HAI ROBOTICS

Series C in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.

HAI ROBOTICS

Series D in 2021
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in autonomous case-handling robotic systems for warehouse automation. The company offers a range of solutions, including intelligent goods-to-person and smart in-plant logistics systems, tailored for diverse operational scenarios. As a pioneer in this field, HAI ROBOTICS launched its first autonomous case-handling robot, HAIPICK, in 2015, which has since evolved through continuous research and development. The HAIPICK system enhances warehouse efficiency significantly, reportedly increasing operational efficiency by three to four times and storage density by 80% to 130%. HAI ROBOTICS holds multiple patents and serves a growing list of clients, providing flexible and customizable automation solutions to optimize warehousing operations and improve overall productivity.

Syrius Robotics

Series B in 2021
Syrius Robotics is a manufacturer of intelligent robots designed for material handling, particularly within factories and logistics environments. Founded in 2018 and headquartered in Shenzhen, China, with an additional office in Beijing, the company specializes in autonomous mobile robots that utilize a self-developed operational system and software platform, supported by AIoT cloud services. Syrius Robotics partners with fulfillment centers and warehouses globally, offering versatile automation solutions tailored for e-commerce, retail, and logistics sectors. Its innovative logistics robots, which incorporate advanced technologies such as laser radar and cameras, aim to enhance productivity in automated logistics and warehouse operations. The company's solutions are increasingly being adopted by various commercial organizations beyond the transportation industry, demonstrating its broad applicability and impact on efficiency in different sectors.

XtalPi Technology

Series D in 2021
XtalPi Inc. is a pharmaceutical technology company that focuses on digital drug development solutions, leveraging quantum mechanics and artificial intelligence to enhance the efficiency of drug research and development. Founded in 2014 by a group of quantum physicists at MIT, the company has developed its Intelligent Digital Drug Discovery and Development (ID4) platform, which integrates advanced cloud computing algorithms to aid pharmaceutical firms in critical stages of drug R&D. XtalPi offers various tools, including XtalForc for visual force field calculations, XtalVision for crystal structure predictions, and Renova for platform support of its AI research initiatives. Its comprehensive services encompass crystal structure determination, solid-state testing, small molecule drug design, and collaborations in antibody and peptide research. Based in Cambridge, Massachusetts, with additional offices in China, XtalPi has established strategic partnerships with leading international pharmaceutical companies, demonstrating the broad applicability and recognition of its innovative technologies across the pharmaceutical value chain.

Miaoshou Doctor

Series F in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.

Anovent Pharmaceutical

Venture Round in 2021
Shanghai Anovent Pharmaceutical Co., Ltd., founded in 2017 and headquartered in Shanghai, China, specializes in the development of high-quality inhalation medicines tailored for hospitals and medical institutions. The company focuses on offering safe and affordable pharmaceutical products, which include both generic and specialized inhalation therapies. By providing these medications, Anovent aims to enhance the quality of medical treatment available to patients in healthcare settings.

Bota Biosciences

Series B in 2021
Bota Biosciences is a global industrial biotechnology company based in Hangzhou, China, founded in 2019. The company specializes in synthetic bioengineering technology for bio-manufacturing, focusing on developing efficient, eco-friendly, and cost-effective biomanufacturing processes. Bota has created an integrative bioengineering platform that connects biological design with scale-up manufacturing, facilitating the production of high-performing industrial compounds through advanced fermentation processes. To support its innovative solutions, Bota has established a pilot plant and manufacturing facility, which enables the company to deliver scalable industrial solutions and market-ready products. Its infrastructure is designed to assist customers and partners across various industries, including nutrition, food, personal care, and animal health. Bota Biosciences is committed to accelerating shifts toward sustainable living by leveraging its multidisciplinary team's expertise to drive impactful biotech innovations.

Phabuilder

Angel Round in 2021
PhaBuilder is a technology-driven company established in February 2021 by Professor Guoqiang Chen, specializing in synthetic biology with a focus on the engineering application of halophilic microbes. The company employs advanced techniques in Next Generation Industrial Biotechnology to create high-value products such as biodegradable polyhydroxyalkanoates (PHA), ectoine, and cadaverine, targeting multiple sectors, including materials and pharmaceuticals. PhaBuilder is currently constructing two PHA production facilities in China and aims to establish 3-5 large-scale production sites within five years. The company utilizes an interdisciplinary approach that combines biology, engineering, and information technology to transform genetic programs, thereby offering sustainable solutions across diverse fields. With significant backing from notable investors, PhaBuilder is dedicated to integrating synthetic biotechnology into everyday life and advancing intelligent biological manufacturing, with the overarching goal of fostering a greener future through microbial innovation.

Cloudwise

Series E in 2021
Founded in 2009, Cloudwise is a prominent provider of full-stack Artificial Intelligence for IT Operations (AIOps) solutions in China. The company focuses on optimizing IT operations, electric power IT operations, and Internet of Things (IoT) operations through its comprehensive platform, which encompasses IT Operations Management (ITOM), IT Operations Analytics (ITOA), IT Service Management (ITSM), DevOps, and IoT. Cloudwise has invested significantly in independent research and development, resulting in a robust industrial landscape. Headquartered in Beijing, the company operates three R&D centers in Beijing, Yanjiao, and Zhengzhou, along with three operational centers in Shanghai, Guangzhou, and Chengdu. Additionally, it has branches in Hong Kong, Singapore, Thailand, and Malaysia, providing extensive marketing services and technical support throughout China and Southeast Asia, thereby enhancing business operations and decision-making for its clients.

Westlake Therapeutics

Venture Round in 2021
Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in developing innovative cell therapies aimed at treating a range of human diseases, including cancer, rare disorders, and immunological and metabolic conditions. Central to its approach is the REDx platform, which enables the engineering of red blood cells and utilizes genetic modifications of hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood. This technology facilitates the creation of personalized treatment solutions, enhancing the potential for effective therapies tailored to individual patient needs.

HeyTea

Series D in 2021
HeyTea is a Chinese tea shop that focuses on innovative beverages, particularly cheese-topped tea and fruit tea. Founded in 2012 in an alley by the riverside, the company initially operated under the name ROYALTEA before rebranding to HEYTEA. The franchise offers a diverse range of products, including instant milk tea, fruit tea, and traditional Chinese tea, aimed at providing customers with unique flavor combinations. Through its distinct offerings, HeyTea has established itself as a prominent player in the tea beverage market.

Market Kurly

Series F in 2021
Market Kurly is an online grocery service based in Seoul, South Korea, that specializes in the delivery of fresh and premium food products. Founded in 2014, the platform allows users to order a wide range of items, including vegetables, fruits, meats, dairy, baked goods, and processed foods, all sourced directly from producers. Market Kurly focuses on providing high-quality ingredients and offers next-day delivery, ensuring that customers receive their orders promptly. The service also includes non-perishable items, enabling shoppers to conveniently access a variety of groceries. Through its innovative logistics and delivery system, Market Kurly aims to enhance the grocery shopping experience by transforming the way food is produced and distributed.

dMed

Series C in 2021
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

neoX Biotech

Venture Round in 2021
neoX Biotech is a Beijing-based biotechnology company founded in 2018 that specializes in the development of antigen-based cancer vaccines. By integrating artificial intelligence with biophysics, neoX Biotech focuses on the discovery and development of macromolecular and multispecific drugs, primarily in the field of immuno-oncology. The company has established a platform for early therapeutic discovery, which includes neoantigen prediction and T cell receptor screening, as well as the characterization of protein-protein interactions. This innovative approach aims to provide effective treatments for cancer patients by advancing drug research and development.

AgileX

Venture Round in 2021
AgileX Robotics (Dongguan) Co., Ltd is a manufacturer based in Dongguan, China, with an additional office in Shenzhen. Founded in 2017, the company specializes in designing and producing mobile robot products, including unmanned ground vehicles (UGVs) and automated guided vehicles (AGVs). AgileX's offerings cater to various industries such as logistics, security, agriculture, and animal husbandry. The company aims to provide innovative solutions that enhance operational efficiency and reduce the manual workload through advanced robotics technology. Their products are utilized in applications such as security inspection, industrial park operations, agricultural irrigation, and scientific research, demonstrating a commitment to advancing intelligent robotics for broader workforce liberation.

Chehaoduo

Series E in 2021
Chehaoduo designs an online car trading platform that sells used cars. Its online car trading platform directly links individual car sellers and buyers, which help buyers remove the middlemen as well as purchase used cars easily. Haoyong Yang founded Chehaoduo in 2014, with its headquarters in Beijing in China, with branches in Chinese cities such as Hangzhou and Chongqing.

SmartHR

Series D in 2021
SmartHR, Inc. is a Tokyo-based company that specializes in developing cloud-based human resources management software. Founded in 2013, SmartHR provides a comprehensive platform designed to automate procedures related to social insurance and employment insurance. The software enables users to fill out online forms and generate digital versions of essential documents such as pension and employment insurance paperwork, which can be submitted electronically. By offering a suite of technology-enabled solutions for employee management, talent management, and overall HR administration, SmartHR caters to a wide range of businesses, from large enterprises to small and medium-sized enterprises. Through its innovative approach, SmartHR aims to streamline HR processes and enhance employee productivity.

Qingteng Cloud Security

Series C in 2021
Qingteng Cloud Security is a Beijing-based company that specializes in cloud security solutions, particularly focusing on endpoint adaptive security. Founded in 2014, it offers a comprehensive suite of security software that integrates prediction, prevention, detection, and response capabilities. The company's products are built on Adaptive Security Architecture, enabling organizations to enhance their security postures across various industries. Qingteng's asset inventory data platform is capable of identifying over 800 types of business applications and managing key assets across multiple mainframes. This platform supports the development of information security systems that comply with domestic laws and regulations, catering to government and enterprise needs. Additionally, Qingteng provides next-generation host security technology, ensuring robust protection for critical endpoints.

Micro Connect

Series A in 2021
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.

Mech-Mind Robotics

Series C in 2021
Mech-Mind Robotics Technologies is a prominent manufacturer based in Beijing, China, specializing in hardware and software solutions for the logistics industry. Founded in 2016, the company produces advanced smart cameras, including the Mech-Eye series, which are designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind also develops AI-powered software that enables robotic cameras to identify and process objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in tackling complex automation challenges, including bin picking and assembly tasks, thereby enhancing operational efficiency in the e-commerce and logistics sectors. The company further extends its reach with an office in Munich, Germany, and a sales office in Shanghai, China.

Beisen

Series F in 2021
Beijing Beisen Cloud Computing Co., Ltd. specializes in developing software as a service (SaaS) solutions for integrated talent management. Founded in 2005 and based in Beijing, the company offers a comprehensive platform that includes services for talent assessment, recruitment management, performance management, succession planning, and employee development. Beisen’s Human Resource Service Platform focuses on internet recruitment, while its Business People Service Network provides information and recruitment services. The company also delivers platform as a service (PaaS) for cloud architecture development, along with system implementation and custom development services. Its iTalentX platform features cloud-native applications designed to streamline human capital management (HCM) processes, enabling organizations to effectively recruit, evaluate, and retain talent throughout the employee lifecycle.

EdiGene

Series B in 2021
EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

Connect Medical Value Technology

Series A in 2021
Connect Medical Value Technology is a company established in 2020 and based in Hangzhou, Zhejiang, China. It specializes in developing mobile applications designed for physicians, offering a comprehensive platform that integrates clinical services, scientific research, and educational resources. The company's applications leverage advanced artificial intelligence technology to enhance medical practice and improve healthcare delivery. Through its innovative solutions, Connect Medical Value aims to support healthcare professionals in their clinical decision-making and ongoing education.

Qihan Biotech

Series A in 2021
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on addressing the global shortage of organ donors. The company aims to produce safe and effective cells, tissues, and organs for human transplantation using advanced gene editing techniques. By applying these technologies to xenogenic organ transplantation, Qihan Biotech seeks to create organs that can be transplanted into humans, thereby reducing the need for traditional organ transplants and saving lives.

Neuracle

Series B in 2021
Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed through collaboration with Tsinghua University, Neuracle focuses on innovative research in neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs and other tools that allow healthcare institutions to monitor patients' brain bioelectricity levels and accurately diagnose neural conditions. Neuracle's research and development efforts have garnered acceptance from experts in both neuroscience and clinical medicine, positioning the company as a leader in its field and a key contributor to national science and technology initiatives.

MetaX

Seed Round in 2021
Muxi is dedicated to providing full-stack GPU chips and heterogeneous computing solutions that can be widely used in cutting-edge fields such as artificial intelligence, smart cities, data centers, cloud computing, autonomous driving, digital twins, metaverse, and so on. It builds full-stack GPU chip products, launching MXN series GPUs (Xi Si) for AI reasoning, MXC series GPUs (Xi Yun) for AI training and general computing, and MXG series GPUs (Xi Cai) for graphics rendering, Meet the computing power requirements of data centers for "high energy efficiency" and "high versatility". Mu Xi's products all use independently developed GPU IP, have instruction sets and architectures with completely independent intellectual property rights, and are outfitted with a complete software stack (MACAMACA) compatible with mainstream GPU ecosystems. In September 2020, the company was founded in Shanghai, and it has wholly-owned subsidiaries and R&D centers in Beijing, Nanjing, Chengdu, Hangzhou, Shenzhen, and Wuhan.

Tim Hortons China

Venture Round in 2021
Tim Hortons China is a subsidiary of Tim Hortons Inc., established in 2018 and headquartered in Shanghai. The company operates a chain of coffee restaurants that serve a variety of coffee products alongside food offerings, including made-to-order shrimp sandwiches and salads. Tim Hortons China emphasizes customer service, addressing inquiries through multiple channels such as phone, email, and online applications. The company aims to provide a unique dining experience by blending coffee culture with fresh meal options in the Chinese market.

Moore Threads

Seed Round in 2021
Founded in 2020, Moore Threads specializes in developing Graphics Processing Unit technology for corporate clients across sectors such as gaming, creative industries, and artificial intelligence. Its GPU solutions cater to data centers, edge computing servers, professional workstations, and high-performance PCs.

Furong Xingsheng

Venture Round in 2021
Furong Xingsheng is a Chinese company based in Changsha that owns and operates convenience stores. Established in 2009, it specializes in providing B2B logistics and distribution services. The company also functions through its community shopping platform, Xingsheng Youxuan, launched in 2018, which caters to consumers by offering fresh produce, meat, seafood, staples, and general merchandise. This platform employs a unique retail model that combines online ordering with offline pick-up, allowing household consumers to meet their daily needs conveniently through a network of community-based convenience stores.

Neurophth Therapeutics

Series B in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Babycare

Series B in 2021
Babycare is an e-commerce platform providing products for new parents and children. The company specializes in the design, research, and development of mother-baby products. Its products are based on recommendations by a series of research and experiments regarding orthopedic development of babies. One of its products is the infant waist carrier, which is crafted to improve the comfortability of infants and prevent from bowleg posturing which hinders blood circulation. The company is committed to achieving the aspiration of being product designers and baby caretakers. The company was founded in 2014 and is headquartered in Shanghai, China.

neoX Biotech

Series A in 2021
neoX Biotech is a Beijing-based biotechnology company founded in 2018 that specializes in the development of antigen-based cancer vaccines. By integrating artificial intelligence with biophysics, neoX Biotech focuses on the discovery and development of macromolecular and multispecific drugs, primarily in the field of immuno-oncology. The company has established a platform for early therapeutic discovery, which includes neoantigen prediction and T cell receptor screening, as well as the characterization of protein-protein interactions. This innovative approach aims to provide effective treatments for cancer patients by advancing drug research and development.

WeShine Network

Series A in 2021
WeShine Network is a marketing and service platform based in Nanjing, China, established in 2015. The company specializes in providing integrated marketing solutions, primarily utilizing the WeChat platform to facilitate corporate account management for business users. WeShine Network enables enterprises to attract and acquire customers through various channels, enhancing their marketing precision and broadening their customer base. With over 150,000 businesses served and more than 30,000 paid enterprise users, the company has built a substantial presence globally, supported by a network of over 600 channel partners. Its offices are located in major cities such as Guangzhou, Shenzhen, Beijing, Shanghai, Wuxi, and Wuhan.

Xiaobangguihua

Series B in 2021
Xiaobangguihua is an intelligent investment advisory service platform tailored for Chinese middle-class families. The company offers financial management and risk education through personalized consultation plans, enabling clients to make informed investment decisions. Leveraging advanced artificial intelligence algorithms and sophisticated asset allocation models, Xiaobangguihua provides systematic financial solutions aimed at optimizing investment outcomes. Its services include various tools and applications designed to assist users in managing their finances effectively. The company’s mission is to empower individuals to improve their financial literacy and utilize their resources more wisely.

4Paradigm

Series D in 2021
4Paradigm is a leading artificial intelligence technology company that empowers enterprises to improve efficiency, reduce risks, and derive greater value from data through accurate prediction and mining. It specializes in migration learning, considered the next generation of AI technology.

Lalamove

Series F in 2021
Lalamove, originally launched as EasyVan in December 2013 in Hong Kong, is an on-demand logistics platform that connects customers with driver-partners for rapid delivery services. Operating in 21 markets across Asia and Latin America, the company serves over 7 million customers and boasts a network of more than 700,000 drivers. Lalamove has transformed traditional van hiring by enabling instant matches between customers and drivers, often within 12 seconds. The platform facilitates same-day deliveries, typically completing local deliveries within 55 minutes. Additionally, Lalamove provides features such as real-time vehicle tracking and driver ratings, allowing businesses to efficiently scale their delivery operations while optimizing drivers’ routes and earnings.

NuProbe

Series B in 2021
NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Visen Pharmaceuticals

Series B in 2021
Visen Pharmaceuticals is an innovative biopharmaceutical company focused on developing and providing advanced treatments for endocrine diseases in China. With a patient-centric approach, Visen aims to deliver first-in-class or best-in-class products, covering both common and rare endocrine conditions in adults and children. The company leverages cutting-edge technologies and global resources, with established offices in Shanghai, Beijing, Hong Kong, and Taipei, along with a Greater China R&D and manufacturing site in Suzhou.

Hive Box Technology

Series C in 2021
Founded in 2015 and based in Shenzhen, China, Hive Box Technology operates a network of self-service package drop-off and pick-up stations primarily aimed at enhancing the logistics of express delivery and e-commerce. The company has developed a 24-hour self-service platform that allows customers to conveniently store and retrieve packages at their leisure, thereby improving the efficiency of package handling in residential areas. By focusing on accessibility and user experience, Hive Box facilitates seamless interactions between consumers and logistics services, positioning itself as a key player in the evolving landscape of package delivery in China.

STARLINK

Series B in 2021
STARLINK is an online technology company founded in 2017 and based in Shenzhen, China, with additional offices in Chengdu and Xuzhou. The company focuses on developing an e-commerce platform that connects global customers with high-quality light industrial products from China. STARLINK specializes in a diverse range of offerings, including apparel, home goods, and outdoor products, leveraging technology to enhance and integrate the supply chain. By streamlining access to these products, STARLINK aims to serve overseas markets effectively, ensuring a broad selection and efficient delivery for its users.

Insight Lifetech

Series C in 2020
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

Zuoyebang

Series E in 2020
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company offers a web and mobile learning platform tailored for primary and high school students, providing a range of educational products and services. Its platform leverages artificial intelligence to allow students to upload homework questions and search for answers to their academic queries. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has garnered significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.

Lalamove

Series E in 2020
Lalamove, originally launched as EasyVan in December 2013 in Hong Kong, is an on-demand logistics platform that connects customers with driver-partners for rapid delivery services. Operating in 21 markets across Asia and Latin America, the company serves over 7 million customers and boasts a network of more than 700,000 drivers. Lalamove has transformed traditional van hiring by enabling instant matches between customers and drivers, often within 12 seconds. The platform facilitates same-day deliveries, typically completing local deliveries within 55 minutes. Additionally, Lalamove provides features such as real-time vehicle tracking and driver ratings, allowing businesses to efficiently scale their delivery operations while optimizing drivers’ routes and earnings.

Huolala

Series E in 2020
Huolala offers logistics services, moving, less-than-truckload, car rental and sales, and after-car services. Founded in 2013 and grown in the Guangdong-Hong Kong-Macao Greater Bay Area.

dMed

Series C in 2020
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

CassTime

Series C in 2020
CassTime is an industrial internet company based in China that focuses on the automotive aftermarket. The company operates a comprehensive trading platform that offers full coverage of spare parts, facilitating transactions between buyers and sellers. In addition to its marketplace, CassTime provides a software-as-a-service (SaaS) management system tailored for automotive workshops, enhancing operational efficiency. The company also engages in supply chain finance and offers logistics services, ensuring streamlined processes for its users. By delivering detailed information on vehicle parts and supporting simpler settlements and aftersales services, CassTime enables a complete business-to-business transaction experience in the auto parts sector.

SciNeuro

Series A in 2020
SciNeuro Pharmaceuticals is a biotechnology company based in Shanghai, China, focused on developing innovative medicines for patients with central nervous system (CNS) diseases. The company is committed to transforming the treatment landscape for these conditions through a robust product pipeline that emphasizes internal innovation and global collaboration. SciNeuro's drug development is guided by breakthrough scientific evidence, including insights from human genetics and pharmacology, targeting the underlying mechanisms of CNS diseases. By addressing these pathological mechanisms, SciNeuro aims to provide transformative therapies that not only aim to cure these diseases but also enhance the quality of life for patients.

Moore Threads

Seed Round in 2020
Founded in 2020, Moore Threads specializes in developing Graphics Processing Unit technology for corporate clients across sectors such as gaming, creative industries, and artificial intelligence. Its GPU solutions cater to data centers, edge computing servers, professional workstations, and high-performance PCs.

Jiangxing Intelligence

Series A in 2020
Jiangxing Intelligence Inc., founded in 2018 and headquartered in Beijing, China, specializes in the development and operation of artificial intelligence-driven cloud-side collaborative Internet of Things (IoT) devices. The company provides innovative solutions such as EdgeBox, which facilitates real-time processing of big data and AI for industrial sectors, including manufacturing, oil and gas, hydropower, transportation, mining, renewable energy, and smart cities. Additionally, Jiangxing Intelligence offers the Ubiquitous Wisdom Eye, an intelligent monitoring device designed for transmission lines that integrates data from various sensors to create a comprehensive supervision platform. Founded by Professor Liu Jiangchuan, a recognized academician and IEEE Fellow, the company is dedicated to advancing edge computing technology and its applications in energy, industrial security, and intelligent warehousing. With additional offices in Shenzhen and Nanjing, Jiangxing Intelligence aims to enhance operational efficiency and safety in large-scale systems across multiple industries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.